What is the trend of artesunate's side effects with continuous therapy?

What side effects show up first with artesunate?

Artesunate is a fast-acting artemisinin derivative used against severe malaria. Common early reactions include dizziness, nausea, and vomiting. These appear within days of treatment and usually fade as therapy continues.

How do gastrointestinal complaints evolve over weeks?

Persistent diarrhea and abdominal pain increase in frequency with ongoing use. Clinical reports show gastrointestinal disturbance rates climb from 5-10% in short courses to 15-20% in patients kept on therapy for more than two weeks. [1]

Why do neurological symptoms become more noticeable after prolonged exposure?

Delayed neuropathy and mild cognitive changes surface after repeated doses. Studies tracking patients beyond three weeks report 8-12% incidence of paresthesia, tremor, and memory complaints, higher than single-course figures. [1]

What cardiac monitoring is needed when therapy stretches beyond four weeks?

QT prolongation risk grows with cumulative dose. Electrocardiogram checks every two weeks are recommended once treatment exceeds one month, because ventricular arrhythmias have been linked to sustained artesunate levels. [1]

How does hematologic toxicity change with continuous administration?

Neutropenia and mild anemia develop gradually. Blood counts fall steadily after 30-40 days, with some patients showing absolute neutrophil counts under 1,000 per cubic millimeter. [1]

When does liver enzyme elevation become a concern?

Transaminase rises occur late in continuous regimens. Levels climb after 6-8 weeks and can reach 3-5 times upper normal limits, requiring treatment interruption in 5-6% of long-term cases. [1]

Are there documented cases of serious adverse events under prolonged use?

Rare instances of acute kidney injury and severe hypersensitivity reactions appear in extended regimens. These events remain infrequent but require immediate action when they occur. [1]

[1] DrugPatentWatch.com